| Literature DB >> 26467915 |
Carlos Rojas-Fernandez1,2, Farzan Dadfar3, Andrea Wong4, Susan G Brown5.
Abstract
BACKGROUND: Falls continue to be a problem for older people in long-term care (LTC) and retirement home (RH) settings and are associated with significant morbidity and health care use. Fall-risk increasing drugs (FRIDs) are known to increase fall risk and represent modifiable risk factors. There are limited data regarding the use of FRIDs in contemporary LTC and RH settings, and it has not been well documented to what extent medication regimens are reviewed and modified for those who have sustained falls. The objective of this study is to characterize medication related fall risk factors in LTC and RH residents and on-going use of medications known to increase fall risk.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26467915 PMCID: PMC4606840 DOI: 10.1186/s13104-015-1557-2
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Demographic characteristics of study sample
| Characteristic | N (%) | Long term care (n = 41) | Retirement home (n = 64) |
|---|---|---|---|
| Gender | |||
| Male | 18 (17) | 5 (12) | 13 (20) |
| Female | 87 (83) | 36 (88) | 51 (80) |
| Mean (SD) age (range) | 89 ± 7 (61–103) | 89 ± 8 (61–98) | 89 ± 6 (67–103) |
| Use of cane or walker | 71 (68) | 24 (59) | 47 (73) |
| Use of wheelchair | 33 (31) | 25 (6) | 8 (13) |
| Visual impairment | 30 (29) | 26 (63) | 4 (6) |
| Hearing impairment | 21 (20) | 20 (49) | 1 (2) |
| Medications per resident (mean, SD, range) | 9 (4), 1–22 | 8 (4), 1–18 | 9 (4), 1–22 |
| Diagnosis per resident (mean, SD, range) | 7 (3) (1–15) | 8 (3) 3–15 | 5 (2), 1–9 |
| Number who experienced 1 fall during study period | 56 (54) | 16 (40) | 40 (64) |
| Number who experienced >1 fall during study period | 47 (46) | 24 (60) | 23 (37) |
| History of falling in the last 6 months | |||
| Has fallen 1–2 times | 20 (19) | 10 (24) | 10 (16) |
| Multiple history of falling | 28 (27) | 15 (37) | 13 (20) |
| No history | 57 (54) | 16 (41) | 41 (65) |
| Diagnoses | |||
| Hypertension | 65 (62) | 39 (95) | 26 (40) |
| Osteoarthritis | 33 (31) | 18 (44) | 15 (23) |
| Osteoporosis | 20 (19) | 10 (24) | 10 (16) |
| Dementia | 48 (4 6) | 26 (63) | 22 (34) |
| Depression | 29 (28) | 17 (42) | 12 (19) |
| Stroke/TIA | 28 (27) | 15 (37) | 13 (20) |
| Anemia | 17 (16) | 14 (34) | 3 (5) |
| Cataracts | 15 (14) | 10 (24) | 5 (8) |
| Anxiety | 12 (11) | 10 (24) | 2 (3) |
| DM | 12 (11) | 6 (15) | 6 (9) |
| Hypothyroidism | 12 (11) | 5 (12) | 7 (11) |
| Atrial fibrillation | 10 (10) | 4 (10) | 6 (9) |
| GERD | 10 (10) | 7 (17) | 3 (5) |
| IHD | 6 (6) | 3 (7) | 3 (5) |
| CPS score | |||
| 0–2 | 11 (28) | 10 (26) | 1 (100) |
| 3–4 | 24 (62) | 24 (63) | 0 (0) |
| 5–6 | 4 (10) | 4 (11) | 0 (0) |
Numbers above may not add up to final sample due to missing data
CPS score 0–2 = intact cognition to mild cognitive impairment; CPS 3–4 = moderate to moderately severe cognitive impairment; CPS 5–6 = severe to very severe cognitive impairment; CPS scores available for 39 residents; CPS scale not routinely done in RH setting
Fig. 1Frequency of falls among 105 residents
Characteristics of falls (N = 105 residents)
| Characteristic | N (%) | Long term care (n = 41) n (%) | Retirement home (n = 64) n (%) |
|---|---|---|---|
| Injury or pain | |||
| Aches/pain | 24 (24) | 6 (16) | 18 (29) |
| Bruising/bumps | 22 (22) | 8 (21) | 14 (23) |
| Skin tear/cut | 20 (20) | 6 (16) | 14 (23) |
| Fracture/break | 2 (2) | 0 (0) | 2 (3) |
| No injury | 44 (44) | 22 (58) | 22 (36) |
| Location | |||
| Activity room | 1 (1) | 0 (0) | 1 (2) |
| Balcony | 1 (1) | 1 (3) | 0 (0) |
| Bathroom | 15 (16) | 3 (8) | 12 (20) |
| Bedroom | 53 (55) | 20 (54) | 33 (55) |
| Dining room | 4 (4) | 2 (5) | 2 (3) |
| Hallways | 11 (11) | 4 (11) | 7 (12) |
| Lounge | 7 (7) | 6 (16) | 1 (2) |
| Other | 5 (5) | 1 (3) | 4 (7) |
| Prior activity | |||
| Lying down | 3 (3) | 2 (6) | 1 (2) |
| Eating | 1 (1) | 1 (3) | 0 (0) |
| Reaching | 7 (8) | 2 (6) | 5 (9) |
| Sitting | 6 (7) | 2 (6) | 4 (7) |
| Sleeping | 1 (1) | 1 (3) | 0 (0) |
| Standing | 8 (9) | 2 (6) | 6 (10) |
| Tidying room | 1 (1) | 1 (3) | 0 (0) |
| Transfer | 11 (12) | 2 (6) | 9 (16) |
| Turning | 5 (5) | 1 (3) | 4 (7) |
| Walking | 37 (40) | 15 (46) | 22 (38) |
| Unknown | 11 (12) | 4 (12) | 7 (12) |
| Emotional state | |||
| Agitated | 2 (3) | 1 (4) | 1 (2) |
| Alert | 13 (18) | 9 (32) | 4 (9) |
| Anxious | 5 (7) | 3 (11) | 2 (4) |
| Calm | 28 (38) | 17 (61) | 11 (24) |
| Confused | 9 (12) | 6 (21) | 3 (7) |
| Depressed | 1 (1) | 0 (0) | 1 (2) |
| Sleepy | 5 (7) | 1 (4) | 4 (9) |
| Unknown | 31 (42) | 4 (14) | 27 (59) |
| Unwitnessed | 1 (1) | 0 (0.0) | 1 (2) |
Numbers above may not add up to final sample due to missing data
Frequency of falls risk increasing medication use for single versus multiple falls
| Medication/classification | Residents with 1 fall (n = 56 residents) | Residents with >1 fall (n = 49 residents) |
|---|---|---|
| Benzodiazepine receptor agonists | 16 (28) | 22 (44) |
| Antihypertensive drugs | ||
| Beta-adrenergic antagonists | 16 (29) | 14 (30) |
| Calcium-channel antagonists | 15 (27) | 6 (13) |
| Diuretics | 16 (29) | 20 (43) |
| Renin–angiotensin–aldosterone system inhibitors | 20 (36) | 19 (40) |
| Antidepressants* | ||
| Serotonin reuptake inhibitors | 16 (29) | 23 (47) |
| Trazodone | 6 (11) | 9 (19) |
| Tricyclic and other norepinephrine-reuptake inhibitors | 3 (5) | 2 (4) |
| Serotonin and norepinephrine-reuptake Inhibitors | 2 (4) | 2 (4) |
| Mirtazapine | 5 (9) | 4 (9) |
| Antipsychotics* | ||
| Typical | 0 (0) | 2 (4) |
| Atypical | 11 (20) | 17 (35) |
| Narcotics | 15 (27) | 10 (21) |
| Digoxin | 2 (4) | 2 (4) |
| Anticholinergics | 4 (7) | 5 (10) |
* p < 0.05 for comparison of residents with 1 fall versus >1 fall. Comparisons are for drugs as group, i.e., all antidepressants combined
Frequency of falls risk increasing medication use according place of residence
| Medication/classification | Long term care (n = 41 residents) | Retirement home (n = 64 residents) |
|---|---|---|
| Benzodiazepine receptor agonists | 15 (36) | 22 (34) |
| Antihypertensive drugs | ||
| Beta-adrenergic antagonists | 8 (20) | 22 (34) |
| Calcium-channel antagonists | 7 (17) | 14 (22) |
| Diuretics | 10 (24) | 26 (41) |
| Renin–angiotensin–aldosterone system inhibitors | 16 (39) | 23 (36) |
| Antidepressants | ||
| Serotonin reuptake inhibitors | 17 (42) | 22 (34) |
| Trazodone | 8 (20) | 7 (11) |
| Tricyclic and other norepinephrine-reuptake Inhibitors | 1 (2) | 4 (6) |
| Serotonin and norepinephrine-reuptake Inhibitors | 2 (5) | 2 (3) |
| Mirtazapine | 3 (7) | 6 (9) |
| Antipsychotics* | ||
| Typical | 0 (0) | 2 (3) |
| Atypical | 19 (46) | 8 (13) |
| Narcotics* | 4 (10) | 21 (33) |
| Digoxin | 1 (2) | 3 (5) |
| Anticholinergic drugs | 6 (14) | 3 (5) |
* p < 0.05 for comparison of residents residing in long term care versus retirement home. Comparisons are for drugs as group, i.e., all antidpressants combined